首页> 外文OA文献 >Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug. Proposals for designing non-clinical and clinical studies. Is the non-clinical study useful?

【2h】

Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug. Proposals for designing non-clinical and clinical studies. Is the non-clinical study useful?

机译：避免在开发期间和营销新药营销后避免药物临床使用毒性的战略建议。非临床和临床研究的建议。非临床研究是否有用？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Naoki OZAWA;
展开▼
作者单位

展开▼
年度 1996
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Development of a quantification method for digoxin, a typical P-glycoprotein probe in clinical and non-clinical studies, using high performance liquid chromatography-tandem mass spectrometry: The usefulness of negative ionization mode to avoid competitive adduct-ion formation [J] . Hirabayashi H., Sugimoto H., Matsumoto S., Journal of chromatography, B. Analytical technologies in the biomedical and life sciences . 2011,第32期

机译：使用高效液相色谱-串联质谱技术开发一种用于地高辛的定量方法，地高辛是临床和非临床研究中的典型P-糖蛋白探针：负电离模式可避免竞争性加合物离子形成
2. Dasatinib can Impair Left Ventricular Mechanical Function But May Lack Proarrhythmic Effect: A Proposal of Non-clinical Guidance for Predicting Clinical Cardiovascular Adverse Events of Tyrosine Kinase Inhibitors [J] . Izumi-Nakaseko Hiroko, Fujiyoshi Masachika, Hagiwara-Nagasawa Mihoko, Cardiovascular toxicology . 2020,第1期

机译：Dasatinib可以损害左心室机械功能，但可能缺乏预审效应：预测酪氨酸激酶抑制剂的临床心血管不良事件的非临床指导的提议
3. Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies [J] . R.C. Schwanke, J.B. Calixto, J. Cavalli, Brazilian Journal of Medical and Biological Research . 2016,第12期

机译：新药开发过程中的非临床研究-第二部分：良好的实验室操作，新陈代谢，药代动力学，安全性和将剂量转换为临床研究
4. Modeling non-clinical and clinical drug tests in Gaucher disease [C] . Clyde F. Phelix, Allen K. Bourdon, Greg Villareal, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：对高雪氏病的非临床和临床药物测试进行建模
5. Clinical Pharmacokinetics of the Novel Combination of BEZ235, PI3K/mTOR Inhibitor, and Everolimus, mTOR Inhibitor: Phase I Clinical Studies and Non-Clinical Mechanistic Assessment [D] . Moorthy, Ganesh P. 2015

机译：BEZ235，PI3K / mTOR抑制剂和依维莫司，mTOR抑制剂的新型组合的临床药代动力学：I期临床研究和非临床机制评估
6. Evaluation of the Potential Risk of Drugs to Induce Hepatotoxicity in Human—Relationships between Hepatic Steatosis Observed in Non-Clinical Toxicity Study and Hepatotoxicity in Humans- [O] . Keisuke Goda, Akio Kobayashi, Akemi Takahashi, 2017

机译：评价药物在人体内引起肝毒性的潜在风险-非临床毒性研究中观察到的肝脂肪变性与人肝毒性之间的关系
7. Basic strategy for avoiding drug interaction during stage of drug development; The proposals relative to planing of non-clinical and clinical studies how should it be the planing of clinical trials. [O] . Toru HORIE, Hiroshi NAKATA, Kenichi KUSUBE 1996

机译：避免药物发展阶段药物互动的基本策略;关于非临床和临床研究的策划的提议应该如何是临床试验的刨潮。

Strategic proposals for avoiding toxic interactions with drugs for clinical use during development and after marketing of a new drug. Proposals for designing non-clinical and clinical studies. Is the non-clinical study useful?

著录项

引文网络

相似文献

相关主题

期刊订阅